| 12509442 |
KIF18A inhibitors |
Nuria A. Tamayo, Abhisek Banerjee, James Brown, Michael J. Frohn, Jian-Hua Chen +8 more |
2025-12-30 |
|
| 12473289 |
Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use |
Jennifer R. Allen, Albert Amegadzie, Matthew P. Bourbeau, Ning Chen, Clifford GOODMAN +11 more |
2025-11-18 |
|
| 12459932 |
KIF18A inhibitors |
Nuria A. Tamayo, Abhisek Banerjee, James Brown, Michael J. Frohn, Jian-Hua Chen +12 more |
2025-11-04 |
|
| 12440491 |
KRAS G12C inhibitors and methods of using the same |
John Gordon Allen, Jennifer R. Allen, Ana Elena Minatti, Qiufen Xue, Ryan Wurz +22 more |
2025-10-14 |
|
| 12083121 |
Substituted piperazines as KRAS G12C inhibitors |
John Gordon Allen, Brian Alan LANMAN, Jian Chen, Anthony B. Reed, Victor J. Cee +21 more |
2024-09-10 |
$469,902,000 |
| 12054476 |
KIF18A inhibitors |
Nuria A. Tamayo, Abhisek Banerjee, James Brown, Michael J. Frohn, Jian Chen +8 more |
2024-08-06 |
$230,384,000 |
| 11993597 |
Inhibitors of KRAS G12C and methods of using the same |
Brian Alan LANMAN, Shon Booker, Clifford GOODMAN, Anthony B. Reed, Hui-Ling Wang +4 more |
2024-05-28 |
$312,032,000 |
| 11766436 |
KRAS G12C inhibitors and methods of using the same |
John Gordon Allen, Jennifer R. Allen, Ana Elena Minatti, Qiufen Xue, Ryan Wurz +22 more |
2023-09-26 |
$282,576,000 |
| 11306087 |
Inhibitors of KRAS G12C and methods of using the same |
Brian Alan LANMAN, Shon Booker, Clifford GOODMAN, Anthony B. Reed, Hui-Ling Wang +4 more |
2022-04-19 |
$184,680,000 |
| 11285156 |
Substituted piperazines as KRAS G12C inhibitors |
John Gordon Allen, Brian Alan LANMAN, Jian Chen, Anthony B. Reed, Victor J. Cee +21 more |
2022-03-29 |
$231,793,000 |
| 11279712 |
Macrocyclic compounds that inhibit MCL-1 protein |
Sean P. Brown, Yunxiao Li, Paul E. Harrington, Brian Alan LANMAN, Ana Elena Minatti +2 more |
2022-03-22 |
$646,313,000 |
| 11236069 |
KIF18A inhibitors |
Nuria A. Tamayo, Abhisek Banerjee, Jian Chen, Ana Elena Minatti, Matthew P. Bourbeau |
2022-02-01 |
$200,235,000 |
| 11224601 |
Compounds that inhibits MCL-1 protein |
Paul E. Harrington, Kate Ashton, Sean P. Brown, Matthew R. Kaller, Todd J. Kohn +7 more |
2022-01-18 |
$641,433,000 |
| 11090304 |
KRAS G12C inhibitors and methods of using the same |
John Gordon Allen, Jennifer R. Allen, Ana Elena Minatti, Qiufen Xue, Ryan Wurz +22 more |
2021-08-17 |
$335,995,000 |
| 10988485 |
KRAS G12C inhibitors and methods of using the same |
Ana Elena Minatti, Ryan Wurz, Brian Alan LANMAN, Victor J. Cee, Michael D. Bartberger +1 more |
2021-04-27 |
$240,492,000 |
| 10889581 |
Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use |
Jennifer R. Allen, Albert Amegadzie, Matthew P. Bourbeau, Jian Chen, Michael J. Frohn +5 more |
2021-01-12 |
$484,084,000 |
| 10821115 |
Compounds that inhibit Mcl-1 protein |
Paul E. Harrington, Kate Ashton, Sean P. Brown, Matthew R. Kaller, Todd J. Kohn +7 more |
2020-11-03 |
$280,862,000 |
| 10640504 |
Inhibitors of KRAS G12C and methods of using the same |
Brian Alan LANMAN, Shon Booker, Clifford GOODMAN, Anthony B. Reed, Hui-Ling Wang +4 more |
2020-05-05 |
$398,812,000 |
| 10632128 |
Compounds that inhibit Mcl-1 protein |
Paul E. Harrington, Kate Ashton, Sean P. Brown, Matthew R. Kaller, Todd J. Kohn +7 more |
2020-04-28 |
$393,385,000 |
| 9611261 |
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
Ana Elena Minatti, Jennifer R. Allen, Albert Amegadzie, James Brown, Michael J. Frohn +12 more |
2017-04-04 |
$276,197,000 |
| 9593129 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer |
Michael D. Bartberger, Ana Z. Gonzalez Buenrostro, Hilary Plake Beck, Xiaoqi Chen, Richard V. Connors +36 more |
2017-03-14 |
$585,925,000 |
| 9550762 |
Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use |
Jennifer R. Allen, Albert Amegadzie, Matthew P. Bourbeau, James Brown, Jian Chen +21 more |
2017-01-24 |
$492,282,000 |
| 9296736 |
Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer |
Michael D. Bartberger, Ana Z. Gonzalez Buenrostro, Hilary Plake Beck, Xiaoqi Chen, Richard V. Connors +36 more |
2016-03-29 |
$89,902,000 |
| 9296734 |
Perfluorinated 5,6-dihydro-4H-1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
Ana Elena Minatti, Jennifer R. Allen, Jian Chen, Ning Chen, Yuan Cheng +10 more |
2016-03-29 |
$89,902,000 |
| 9085576 |
Perfluorinated cyclopropyl fused 1,3-oxazin-2-amine compounds as beta-secretase inhibitors and methods of use |
Ana Elena Minatti, Jennifer R. Allen, Albert Amegadzie, James Brown, Michael J. Frohn +12 more |
2015-07-21 |
$288,742,000 |